Ozgene is an Australian company that generates customised genetically modified mice for drug validation and medical research trials worldwide. Using Lean Management, we are able to efficiently and consistently provide our clients with high quality mouse models so that you too, can advance humanity and inspire curiosity.
Did you know that Ozgene’s founders, Dr Frank Koentgen and Dr Gabi Suess, were the first to successfully produce a C57BL/6 knockout mouse in 1993? Ozgene was founded in 1999 based on that initial accomplishment. Since then, we have established a long history of continued success. Today Ozgene is one of the leading companies providing genetically customised mice for researchers around the world.
Ozgene mice can be found all over the globe. This is evidenced by the distribution of published papers that reference mice created by Ozgene. We currently have over 400 papers published, more than any other competing company. We would love to add your paper to the list, so if you have a project in mind, please see our current services below and contact us for a confidential, obligation free assessment.
Read about recently published knock-in mouse models that give insights into childhood cancer and into diseases affecting the distal convoluted tubule in the kidneys.
Congratulations go to Dr. Maree Hagan, who has been the first to complete an Ozgene PhD in collaboration with Monash University to study Ki-67 protein and its role in immune cell development.
With all the uncertainty of COVID-19, we hope you are safe and in good health. We want you to know that Ozgene is still here to meet your needs. We have put measures in place to mitigate the impact of the pandemic and at this stage our timelines are not impacted.